IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Recip Buys AstraZeneca Plant

10:05 AM MDT | July 11, 2007 | Chemical Week Editorial Staff

Recip Pharma (Haninge, Sweden), a contract manufacturer, says it has completed the acquisition of AstraZeneca’s sterile products manufacturing plant near Monts, France. Financial terms were not disclosed. Recip Pharma will operate the plant to manufacture and fill vials with a range of AstraZeneca’s anaesthetic products. The acquisition is Recip Pharma’s first outside of Sweden. AstraZeneca says it decided to sell the plant because of growing competition from generic anaesthetic manufacturers. All of AstraZeneca’s staff at the site has...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa